Background: Clarithromycin (Cla) heteroresistance of Helicobacter pylori (H pylori) infections is commonly assessed by comparing the resistance status of antrum and corpus biopsy samples and by demonstrating the discrepancy between them (interniche heteroresistance). However, fluorescence in situ hybridization (FISH) technique is capable of showing the synchronous presence of susceptible and resistant bacteria (intraniche heteroresistance), enabling the detection of heteroresistant H pylori populations within one biopsy sample.
Materials And Methods: Antrum and corpus biopsy specimens of 305 H pylori-infected patients were investigated with an rRNA-targeted Cla-resistance FISH test. Anamnestic data were collected from the institutional electronic register. Prevalence rates of susceptible, homo- and heteroresistant cases were correlated with the anamnestic and clinicopathological data.
Results: Overall Cla-resistance rate was 23.9% (73 cases), consisting of 35 (11.5%) homoresistant and 38 (12.5%) heteroresistant cases. Thirty-five patients had at least one biopsy site where susceptible and resistant bacteria were present simultaneously. From this subset, 20 cases demonstrated intraniche heteroresistance on both sites. Prior Cla-based eradication attempts were more frequent in homoresistant than in susceptible and heteroresistant cases (P < .001, P < .001, respectively). Cla-containing therapy eradicated heteroresistant infections at a significantly lower rate in comparison with susceptible cases (P = .0112), but more effectively than homoresistants (P = .0393).
Conclusions: The most frequent type of Cla-heteroresistance is the coexistence of susceptible and resistant H pylori bacteria in the same location (intraniche heteroresistance). A previous Cla-based eradication attempt predisposes patients to homoresistant infection. Heteroresistance is characterized by a non-eradication-related background and intermediate characteristics in many respects when compared to susceptible and homoresistant cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/hel.12670 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genetic Determinants of Clarithromycin and Fluoroquinolones Resistance in in Serbia.
Antibiotics (Basel)
October 2024
Clinic for Gastroenterology and Hepatology, University Clinical Centre of Serbia, 11 000 Belgrade, Serbia.
Article Synopsis
- - The study investigates the prevalence of stomach infections and their antibiotic resistance, particularly to fluoroquinolones and clarithromycin, highlighting high resistance rates and treatment failures in symptomatic patients.
- - Molecular testing using the GenoType Helico DR kit revealed that 42.4% of patients tested positive for infections, with significant resistance rates at 53.9% for fluoroquinolones and 58.5% for clarithromycin, alongside specific genetic mutations linked to resistance.
- - The findings emphasize the urgent need for antibiotic susceptibility testing and tailored therapy based on the Maastricht VI Consensus recommendations to address the rising rates of resistance and improve treatment outcomes.
Epidemiological, Phylogenetic, and Resistance Heterogeneity Among in a Large U.S. Deep South Healthcare system.
Open Forum Infect Dis
September 2024
Department of Medicine, Division of Infectious Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Background: () disease in the United States is commonly attributed to outbreaks of 1 or 2 monophyletic carbapenem resistance (CR) lineages that vary by region. However, there is limited knowledge regarding CR epidemiology and population structures in the U.S.
View Article and Find Full Text PDFHigh prevalence of polymyxin-heteroresistant carbapenem-resistant Klebsiella pneumoniae and its within-host evolution to resistance among critically ill scenarios.
Infection
August 2024
Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin ER Road, Shanghai, 200025, China.
Article Synopsis
- The study investigated the prevalence and evolution of polymyxin heteroresistance in carbapenem-resistant Klebsiella pneumoniae (PHR-CRKP) in critically ill patients, revealing alarming rates of resistance.
- Out of 109 patients analyzed, almost 70% had PHR-CRKP without prior polymyxin exposure, with 38% of isolates showing polymyxin resistance linked to treatment failures.
- The research identified specific genetic changes contributing to increased resistance and emphasized the need for ongoing monitoring to address the risks associated with this type of bacterial infection.
Prevalence of heteroresistant Helicobacter pylori and treatment follow-up in patients in Ilam, Iran.
GMS Hyg Infect Control
May 2024
Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Background: Special antibiotics are prescribed against . However, sometimes the bacteria are not completely eliminated, or they are recurrent. Unlike most infections, it is very difficult to eliminate a infection.
View Article and Find Full Text PDFIntrinsic clarithromycin heteroresistance in Mycobacterium avium.
J Infect Chemother
August 2024
Department of Microbiology and Infectious Disease, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, Tokyo, 143-8540, Japan.
Background: Mycobacterium avium is associated with pulmonary disease in otherwise healthy adults. Several clarithromycin-refractory cases have been reported, including some cases caused by clarithromycin-susceptible strains.
Objectives: To characterize the reason for the discrepancy between clinical response and antibiotic susceptibility results.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!